Jamjoom Pharmaceuticals Factory Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA15QGU1UNH6
SAR
155.00
-15.6 (-9.14%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With ROE of 27.03%, it has a very attractive valuation with a 5.79 Price to Book Value

  • Over the past year, while the stock has generated a return of 1.24%, its profits have risen by 28.7% ; the PEG ratio of the company is 0.8
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SAR 10,857 Million (Small Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

27.03%

stock-summary
Price to Book

6.32

Revenue and Profits:
Net Sales:
305 Million
(Quarterly Results - Dec 2025)
Net Profit:
68 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.96%
0%
-6.96%
6 Months
1.84%
0%
1.84%
1 Year
13.97%
0%
13.97%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Jamjoom Pharmaceuticals Factory Co. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
16.76%
EBIT Growth (5y)
22.37%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.85
Tax Ratio
5.60%
Dividend Payout Ratio
60.61%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.93%
ROE (avg)
21.80%

Valuation key factors

Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
5.79
EV to EBIT
21.16
EV to EBITDA
19.80
EV to Capital Employed
5.79
EV to Sales
6.62
PEG Ratio
0.75
Dividend Yield
NA
ROCE (Latest)
27.37%
ROE (Latest)
27.03%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 17.29% vs 24.92% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 31.98% vs 15.96% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "304.60",
          "val2": "259.70",
          "chgp": "17.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "71.30",
          "val2": "64.40",
          "chgp": "10.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-2.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "68.10",
          "val2": "51.60",
          "chgp": "31.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "234.10%",
          "val2": "208.60%",
          "chgp": "2.55%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.81% vs 19.78% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 30.10% vs 21.92% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,500.60",
          "val2": "1,318.50",
          "chgp": "13.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "474.80",
          "val2": "418.00",
          "chgp": "13.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.70",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-10.30",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "463.80",
          "val2": "356.50",
          "chgp": "30.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "316.40%",
          "val2": "288.60%",
          "chgp": "2.78%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
304.60
259.70
17.29%
Operating Profit (PBDIT) excl Other Income
71.30
64.40
10.71%
Interest
0.00
0.10
-100.00%
Exceptional Items
0.00
-2.20
100.00%
Consolidate Net Profit
68.10
51.60
31.98%
Operating Profit Margin (Excl OI)
234.10%
208.60%
2.55%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 17.29% vs 24.92% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 31.98% vs 15.96% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,500.60
1,318.50
13.81%
Operating Profit (PBDIT) excl Other Income
474.80
418.00
13.59%
Interest
0.00
0.70
-100.00%
Exceptional Items
0.00
-10.30
100.00%
Consolidate Net Profit
463.80
356.50
30.10%
Operating Profit Margin (Excl OI)
316.40%
288.60%
2.78%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 13.81% vs 19.78% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 30.10% vs 21.92% in Dec 2024

stock-summaryCompany CV
About Jamjoom Pharmaceuticals Factory Co. stock-summary
stock-summary
Jamjoom Pharmaceuticals Factory Co.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available